|
Biotechnology
Companies
Links:
Pharm/Biotech Resources,
Pharm/Biotech Jobs
Stock Quotes as of closing 2/3/2012
| Name |
Symbol |
Trade |
Change |
P/E |
52-wk Range |
Prev Cls |
|
ALSERES PHARMACEUTCL
|
ALSE.PK |
0.36 |
0.02 |
5.26% |
N/A |
0.02 - 0.51 |
0.38 |
|
Affymetrix, Inc.
|
AFFX |
5.14 |
0.00 |
0.00% |
N/A |
3.68 - 8.16 |
5.14 |
|
Albany Molecular Research, Inc.
|
AMRI |
3.04 |
0.01 |
0.33% |
N/A |
2.08 - 5.55 |
3.03 |
|
ALPHARX INC
|
ALRX.OB |
0.0620 |
0.00 |
0.00% |
N/A |
0.02 - 0.07 |
0.06 |
|
Amgen Inc.
|
AMGN |
69.28 |
0.34 |
0.49% |
17.15 |
47.66 - 70.00 |
69.62 |
|
Anika Therapeutics Inc.
|
ANIK |
10.05 |
0.10 |
1.01% |
19.71 |
5.24 - 11.67 |
9.95 |
|
ARIAD Pharmaceuticals, Inc.
|
ARIA |
15.48 |
0.43 |
2.86% |
N/A |
5.52 - 15.44 |
15.05 |
|
AUTOIMMUNE INC
|
AIMM.PK |
0.0050 |
0.00 |
0.00% |
N/A |
- |
0.01 |
|
AVAX TECHS INC
|
AVXT.PK |
0.0550 |
0.00 |
0.00% |
N/A |
- |
0.06 |
|
BioCryst Pharmaceuticals, Inc.
|
BCRX |
4.03 |
0.18 |
4.68% |
N/A |
2.28 - 4.49 |
3.85 |
|
Biogen Idec Inc
|
BIIB |
121.88 |
0.62 |
0.51% |
25.38 |
64.61 - 123.23 |
121.26 |
|
BIOMIMIX, INC.
|
BIOM.PK |
0.0110 |
0.00 |
0.00% |
N/A |
- |
0.01 |
|
Cel-Sci Corporation Common Stoc
|
CVM |
0.3399 |
0.0001 |
0.03% |
N/A |
0.27 - 0.76 |
0.34 |
|
Cerus Corporation
|
CERS |
3.16 |
0.01 |
0.32% |
N/A |
1.92 - 3.67 |
3.17 |
|
Covance Inc. Common Stock
|
CVD |
45.57 |
0.32 |
0.71% |
21.10 |
42.02 - 63.86 |
45.25 |
|
CryoLife, Inc. Common Stock
|
CRY |
5.85 |
0.01 |
0.17% |
20.82 |
4.00 - 5.84 |
5.84 |
|
CytRx Corporation
|
CYTR |
0.2890 |
0.0040 |
1.40% |
N/A |
0.24 - 1.06 |
0.28 |
|
Discovery Laboratories, Inc.
|
DSCO |
2.51 |
0.04 |
1.57% |
N/A |
1.44 - 3.08 |
2.55 |
|
Enzon Pharmaceuticals, Inc.
|
ENZN |
7.76 |
0.11 |
1.44% |
N/A |
6.13 - 11.82 |
7.65 |
|
GENTA INC
|
GNTA.OB |
0.0021 |
0.00 |
0.00% |
N/A |
0.01 - 59.00 |
0.00 |
|
Gilead Sciences, Inc.
|
GILD |
54.69 |
5.38 |
10.92% |
15.98 |
34.45 - 49.63 |
49.31 |
|
Heska Corporation
|
HSKA |
7.85 |
0.01 |
0.13% |
21.69 |
4.84 - 10.28 |
7.86 |
|
IGI, Laboratories Inc. Common S
|
IG |
1.10 |
0.00 |
0.00% |
N/A |
0.85 - 1.80 |
1.10 |
|
Incyte Corporation
|
INCY |
17.66 |
0.41 |
2.27% |
N/A |
11.76 - 21.15 |
18.07 |
|
Integra LifeSciences Holdings C
|
IART |
31.04 |
0.93 |
3.09% |
21.83 |
23.09 - 52.90 |
30.11 |
|
LA JOLLA PHARMA
|
LJPC.PK |
0.0045 |
0.00 |
0.00% |
4.50 |
0.01 - 4.00 |
0.00 |
|
Myriad Genetics, Inc.
|
MYGN |
23.84 |
0.18 |
0.76% |
20.71 |
17.51 - 25.89 |
23.66 |
|
Nabi Biopharmaceuticals
|
NABI |
1.86 |
0.02 |
1.06% |
N/A |
1.50 - 5.90 |
1.88 |
|
NORTH AMERN SCI
|
NASMQ.PK |
0.0001 |
0.00 |
0.00% |
N/A |
- |
0.00 |
|
NPS Pharmaceuticals, Inc.
|
NPSP |
7.99 |
0.29 |
3.77% |
N/A |
4.35 - 10.75 |
7.70 |
|
ONYX Pharmaceuticals, Inc.
|
ONXX |
42.62 |
0.33 |
0.76% |
N/A |
27.17 - 46.07 |
42.95 |
|
OXiGENE, Inc.
|
OXGN |
1.0990 |
0.0390 |
3.68% |
N/A |
0.82 - 6.38 |
1.06 |
|
PANACOS PHARMA INC
|
PANC.PK |
0.0032 |
0.00 |
0.00% |
N/A |
0.01 - 0.02 |
0.00 |
|
PROGEN PHARMACEUTICL
|
PGLA.PK |
0.12 |
0.00 |
0.00% |
N/A |
0.12 - 0.35 |
0.12 |
|
PDL BioPharma, Inc.
|
PDLI |
6.48 |
0.04 |
0.62% |
8.54 |
4.66 - 6.70 |
6.44 |
|
Qiagen N.V.
|
QGEN |
15.91 |
0.04 |
0.25% |
28.93 |
12.47 - 22.20 |
15.95 |
|
Regeneron Pharmaceuticals, Inc.
|
REGN |
96.86 |
1.85 |
1.95% |
N/A |
34.05 - 95.21 |
95.01 |
|
Repligen Corporation
|
RGEN |
4.14 |
0.15 |
3.76% |
N/A |
2.90 - 5.36 |
3.99 |
|
Repros Therapeutics Inc.
|
RPRX |
4.57 |
0.01 |
0.22% |
N/A |
2.60 - 6.85 |
4.56 |
|
Techne Corporation
|
TECH |
66.30 |
0.08 |
0.12% |
21.74 |
62.04 - 86.43 |
66.38 |
|
TITAN PHARMA INC
|
TTNP.OB |
1.35 |
0.17 |
14.41% |
N/A |
1.01 - 2.22 |
1.18 |
|
Vical Incorporated
|
VICL |
3.64 |
0.06 |
1.68% |
N/A |
1.70 - 5.30 |
3.58 |
|
ViroPharma Incorporated
|
VPHM |
30.33 |
0.23 |
0.76% |
20.51 |
14.62 - 30.98 |
30.10 |
|
XOMA Corporation
|
XOMA |
1.34 |
0.00 |
0.00% |
N/A |
1.04 - 5.65 |
1.34 |
**
Pharm Stocks is published as a service for the pharmaceutical community by
www.PharmCast.com. We strive to ensure the accuracy of the stock
quotes. However, please refer to another source of stock quotes
before making any investment decisions.

|